DK0831900T3 - Fremgangsmåder til at rejse antistoffer imod E. Coli i CS4-CFA/1 familien - Google Patents

Fremgangsmåder til at rejse antistoffer imod E. Coli i CS4-CFA/1 familien

Info

Publication number
DK0831900T3
DK0831900T3 DK96918041T DK96918041T DK0831900T3 DK 0831900 T3 DK0831900 T3 DK 0831900T3 DK 96918041 T DK96918041 T DK 96918041T DK 96918041 T DK96918041 T DK 96918041T DK 0831900 T3 DK0831900 T3 DK 0831900T3
Authority
DK
Denmark
Prior art keywords
cfa
family
consensus
peptide
coli
Prior art date
Application number
DK96918041T
Other languages
Danish (da)
English (en)
Inventor
Frederick Cassels
Jeffrey Anderson
John Mark Carter
Original Assignee
Dept Of The Army Us Government
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dept Of The Army Us Government filed Critical Dept Of The Army Us Government
Application granted granted Critical
Publication of DK0831900T3 publication Critical patent/DK0831900T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK96918041T 1995-06-02 1996-06-03 Fremgangsmåder til at rejse antistoffer imod E. Coli i CS4-CFA/1 familien DK0831900T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/460,617 US5914114A (en) 1995-06-02 1995-06-02 Method of raising antibodies against E. coli of the family CS4-CFA/I
PCT/US1996/008730 WO1996038171A1 (en) 1995-06-02 1996-06-03 Methods of raising antibodies against e.coli of the family cs4-cfa/1

Publications (1)

Publication Number Publication Date
DK0831900T3 true DK0831900T3 (da) 2003-07-21

Family

ID=23829417

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96918041T DK0831900T3 (da) 1995-06-02 1996-06-03 Fremgangsmåder til at rejse antistoffer imod E. Coli i CS4-CFA/1 familien

Country Status (8)

Country Link
US (1) US5914114A (es)
EP (1) EP0831900B1 (es)
AT (1) ATE235916T1 (es)
CA (1) CA2223013C (es)
DE (1) DE69627150T2 (es)
DK (1) DK0831900T3 (es)
ES (1) ES2196155T3 (es)
WO (1) WO1996038171A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU734532B2 (en) * 1996-04-19 2001-06-14 Henry M. Jackson Foundation For The Advancement Of Military Medicine Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability
CA2262819C (en) * 1996-08-02 2011-10-04 Department Of The Army, U.S. Government Monoclonal antibody which agglutinates e. coli having the cs4-cfa/i family protein
US7404961B2 (en) * 1996-08-02 2008-07-29 The United States Of America As Represented By The Secretary Of The Army Peptides responsive to antibodies against consensus peptide of the CS4-CFA/I family proteins
US7094883B1 (en) * 1996-08-02 2006-08-22 The United States Of America As Represented By The Secretary Of The Army Monoclonal antibody which agglutinates E. coli having the CS4-CFA/I family protein
EP0959895B1 (en) * 1996-08-02 2004-10-20 Department of the Army, U.S. Government U.S. Army Medical Research & Materiel Command, Elizabeth Arwine Peptides responsive to antibodies against a consensus peptide of the cs4-cfa/i family proteins
US6797276B1 (en) * 1996-11-14 2004-09-28 The United States Of America As Represented By The Secretary Of The Army Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response
US20060002949A1 (en) 1996-11-14 2006-01-05 Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. Transcutaneous immunization without heterologous adjuvant
US20060002959A1 (en) * 1996-11-14 2006-01-05 Government Of The United States Skin-sctive adjuvants for transcutaneous immuization
US5980898A (en) * 1996-11-14 1999-11-09 The United States Of America As Represented By The U.S. Army Medical Research & Material Command Adjuvant for transcutaneous immunization
US7422747B2 (en) * 1997-10-07 2008-09-09 Loma Linda University Transgenic plant-based vaccines
US20040258703A1 (en) * 1997-11-14 2004-12-23 The Government Of The Us, As Represented By The Secretary Of The Army Skin-active adjuvants for transcutaneous immunization
EP1165132B1 (en) * 1999-04-08 2011-10-19 Intercell USA, Inc. Dry formulation for transcutaneous immunization
CA2379129A1 (en) * 1999-07-15 2001-01-25 Medimmune, Inc. Fima pilus-based vaccines
WO2001021655A2 (en) * 1999-09-22 2001-03-29 Isis Innovation Limited Virulence gene and protein, and their use
HUP0300297A3 (en) 2000-04-20 2005-09-28 Univ Maryland Baltimore Baltim Isolation and characterization of the csa operon (etec-cs4 pili) and methods of using same
IES20010042A2 (en) * 2001-01-19 2002-12-11 Enfer Technology Ltd Test for transmissible spongiform encephalopathies
CA2437899C (en) * 2001-02-13 2012-05-15 Gregory M. Glenn Vaccine for transcutaneous immunization against etec-caused traveler's diarrhea
EP1481053B1 (en) * 2002-02-25 2007-09-12 US Army Medical Research & Materiel Command Method of making cs6 antigen vaccine for treating, preventing, or inhibiting enterotoxigenic escherichia coli infections
WO2006127798A2 (en) * 2005-05-24 2006-11-30 The United States Of America As Represented By The Secretary Of The Navy Anti-adhesin based passive immunoprophylactic

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4411888A (en) * 1981-06-22 1983-10-25 The University Of Rochester Composition of a novel immunogen for protection against diarrheal disease caused by enterotoxigenic Escherichia coli
US4443549A (en) * 1981-10-19 1984-04-17 Molecular Genetics, Inc. Production of monoclonal antibodies against bacterial adhesins
US4971794A (en) * 1982-09-02 1990-11-20 Unilever Patent Holdings B.V. Production of antibodies using a mixture of strains of E. coli collectively expressing type I pili, CFA I pili, CFA II pili and K88 pili
US5417986A (en) * 1984-03-16 1995-05-23 The United States Of America As Represented By The Secretary Of The Army Vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
US5017372A (en) * 1986-04-14 1991-05-21 Medicis Corporation Method of producing antibody-fortified dry whey
ES2042718T3 (es) * 1987-10-26 1993-12-16 Akzo Nv Procedimiento para la preparacion de una vacuna para proteger aves de corral contra septicemia producida por e. coli.
US5190746A (en) * 1989-05-10 1993-03-02 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Plaque inhibiting oligosaccharide
US5071977A (en) * 1989-05-10 1991-12-10 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Plaque inhibiting oligosaccharide
WO1992001703A1 (en) * 1990-07-24 1992-02-06 Emory University Production of and compositions for the major cs1 pilin antigen including vaccines and diagnostic probes
US5698416A (en) * 1995-06-02 1997-12-16 The United States Of America As Represented By The Secretary Of The Army Methods for production of antigens under control of temperature-regulated promotors in enteric bacteria
US5627163A (en) * 1995-06-05 1997-05-06 Synsorb Biotech, Inc. Treatment of traveller's diarrhea
US5637576A (en) * 1995-06-05 1997-06-10 Synsorb Biotech, Inc. Treatment of traveller's diarrhea

Also Published As

Publication number Publication date
US5914114A (en) 1999-06-22
ES2196155T3 (es) 2003-12-16
EP0831900B1 (en) 2003-04-02
DE69627150T2 (de) 2004-01-29
EP0831900A1 (en) 1998-04-01
CA2223013A1 (en) 1996-12-05
WO1996038171A1 (en) 1996-12-05
DE69627150D1 (de) 2003-05-08
EP0831900A4 (en) 1999-01-20
CA2223013C (en) 2011-03-22
ATE235916T1 (de) 2003-04-15

Similar Documents

Publication Publication Date Title
DK0831900T3 (da) Fremgangsmåder til at rejse antistoffer imod E. Coli i CS4-CFA/1 familien
DE69333802D1 (de) Äusseres membranprotein von haemophilus
ATE393823T1 (de) Nukleinsäure bindende proteine
Rüchel A variety of Candida proteinases and their possible targets of proteolytic attack in the host
DE69018142D1 (de) Stressproteine aus Pilzen.
EP0994724A4 (en) METHODS AND COMPOSITIONS TO PREVENT THE REPRODUCTION OF HIV-1
BR9810907A (pt) Anticorpos monoclonais e policlonais, peptìdeo suscetìvel de gerar um anticorpo, agente imunogênico, sequência de nucleotìdeos, composição farmacêutica, uso de pelo menos um anticorpo, kit de diagnóstico, e, processo para preparar um agente imunogênico
CA2217522A1 (en) Isolated frpb nucleic acid molecule and vaccine
KR980002066A (ko) 변이형 인간 성장호르몬 및 그의 용도
ATE121754T1 (de) Vakzine gegen bordetella.
ATE482272T1 (de) Zytokinproteinfamilie
ATE184612T1 (de) Peptidzusammensetzung aus pseudomonas und methode diese herzustellen
WO1996018646A3 (en) Heat shock protein peptides and methods for modulating autoimmune central nervous system disease
DK38889D0 (da) Onkogen-indkodet polypeptid med vaekstfaktoraktivitet
EP0312157A3 (en) Tetrapeptide renin inhibitors having a novel c-terminal amino acid
DE59208025D1 (de) Neue thrombininhibitorische proteine aus landblutegeln
ATE103979T1 (de) Menschliches lymphotoxin.
ATE441713T1 (de) Tumorantigenprotein und dessen verwendung
TH14996EX (th) วัคซีนป้องกันโรคติดเชื้อสเตร็ปโตคอคคัส ซูอิส
SE0002728D0 (sv) New compound